APO Research
Talk to an analyst

APO RESEARCH · REPORT

Therapeutic Drug Monitoring

Therapeutic drug monitoring (TDM) is the clinical practice of measuring specific drugs at designated intervals to maintain a constant concentration in a patient's bloodstream, thereby optimizing individual dosage regimens. It is unnecessary to employ TDM for the majority of medications, and it is used mainly for monitoring drugs with narrow therapeutic ranges, drugs with marked pharmacokinetic variability, medications for which target concentrations are difficult to monitor, and drugs known to cause therapeutic and adverse effects. The process of TDM is predicated on the assumption that there is a definable relationship between dose and plasma or blood drug concentration, and between concentration and therapeutic effects. TDM begins when the drug is first prescribed, and involves determining an initial dosage regimen appropriate for the clinical condition and such patient characteristics as age, weight, organ function, and concomitant drug therapy. When interpreting concentration measurements, factors that need to be considered include the sampling time in relation to drug dose, dosage history, patient response, and the desired medicinal targets. The goal of TDM is to use appropriate concentrations of difficult-to-manage medications to optimize clinical outcomes in patients in various clinical situations.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Therapeutic drug monitoring (TDM) is the clinical practice of measuring specific drugs at designated intervals to maintain a constant concentration in a patient's bloodstream, thereby optimizing individual dosage regimens. It is unnecessary to employ TDM for the majority of medications, and it is used mainly for monitoring drugs with narrow therapeutic ranges, drugs with marked pharmacokinetic variability, medications for which target concentrations are difficult to monitor, and drugs known to cause therapeutic and adverse effects. The process of TDM is predicated on the assumption that there is a definable relationship between dose and plasma or blood drug concentration, and between concentration and therapeutic effects. TDM begins when the drug is first prescribed, and involves determining an initial dosage regimen appropriate for the clinical condition and such patient characteristics as age, weight, organ function, and concomitant drug therapy. When interpreting concentration measurements, factors that need to be considered include the sampling time in relation to drug dose, dosage history, patient response, and the desired medicinal targets. The goal of TDM is to use appropriate concentrations of difficult-to-manage medications to optimize clinical outcomes in patients in various clinical situations.

Selected research

Market Analysis & Forecast

Global Therapeutic Drug Monitoring Market Analysis and Forecast 2026-2032

1 January 2026190 pages

Choose your research edition.

Industry ResearchTherapeutic Drug Monitoring Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Therapeutic Drug Monitoring Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Therapeutic Drug Monitoring Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Therapeutic Drug Monitoring Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Therapeutic Drug Monitoring Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

Therapeutic drug monitoring (TDM) is the clinical practice of measuring specific drugs at designated intervals to maintain a constant concentration in a patient's bloodstream, thereby optimizing individual dosage regimens. It is unnecessary to employ TDM for the majority of medications, and it is used mainly for monitoring drugs with narrow therapeutic ranges, drugs with marked pharmacokinetic variability, medications for which target concentrations are difficult to monitor, and drugs known to cause therapeutic and adverse effects. The process of TDM is predicated on the assumption that there is a definable relationship between dose and plasma or blood drug concentration, and between concentration and therapeutic effects. TDM begins when the drug is first prescribed, and involves determining an initial dosage regimen appropriate for the clinical condition and such patient characteristics as age, weight, organ function, and concomitant drug therapy. When interpreting concentration measurements, factors that need to be considered include the sampling time in relation to drug dose, dosage history, patient response, and the desired medicinal targets. The goal of TDM is to use appropriate concentrations of difficult-to-manage medications to optimize clinical outcomes in patients in various clinical situations.

Roche, Danaher and Abbott are the major companies in the industry, accounting for 17.17%, 10.36% and 8.29% of the revenue respectively in 2019. By region, North America had the highest share of income, reaching 42.31 percent in 2019.

Report Includes

Read the full market overview

This report presents an overview of global market for Therapeutic Drug Monitoring, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Therapeutic Drug Monitoring, also provides the revenue of main regions and countries. Of the upcoming market potential for Therapeutic Drug Monitoring, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Therapeutic Drug Monitoring revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Therapeutic Drug Monitoring market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Therapeutic Drug Monitoring revenue, projected growth trends, production technology, application and end-user industry.

Therapeutic Drug Monitoring Segment by Company

Roche

Danaher

Abbott

Thermo Fisher Scientific

Siemens Healthcare

Bio-Rad Laboratories

BioMerieux

Sanquin

Becton Dickinson

Quest Diagnostics

Therapeutic Drug Monitoring Segment by Type

Blood Test

Urine Test

Saliva Test

Other Test

Therapeutic Drug Monitoring Segment by Application

Hospital Labs

Private Labs

Others

Therapeutic Drug Monitoring Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Therapeutic Drug Monitoring market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Therapeutic Drug Monitoring and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Therapeutic Drug Monitoring.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Therapeutic Drug Monitoring in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Therapeutic Drug Monitoring company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Therapeutic Drug Monitoring revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Therapeutic Drug Monitoring Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Blood Test Major Player Table 3. Urine Test Major Player Table 4. Saliva Test Major Player Table 5. Other Test Major Player Table 6. Global Therapeutic Drug Monitoring Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Hospital Labs Major Player Table 8. Private Labs Major Player Table 9. Others Major Player Table 10. Therapeutic Drug Monitoring Industry Trends Table 11. Therapeutic Drug Monitoring Industry Drivers Table 12. Therapeutic Drug Monitoring Industry Opportunities and Challenges Table 13. Therapeutic Drug Monitoring Industry Restraints Table 14. Global Therapeutic Drug Monitoring Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Therapeutic Drug Monitoring Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Therapeutic Drug Monitoring Market Share by Region (2021-2026) Table 17. Global Therapeutic Drug Monitoring Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Therapeutic Drug Monitoring Market Share by Region (2027-2032) Table 19. Global Therapeutic Drug Monitoring Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Therapeutic Drug Monitoring Revenue Market Share by Players (2021-2026) Table 21. Global Therapeutic Drug Monitoring Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Therapeutic Drug Monitoring Key Players Headquarters & Area Served Table 23. Global Therapeutic Drug Monitoring Players, Product Type & Application Table 24. Global Therapeutic Drug Monitoring Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Therapeutic Drug Monitoring by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Therapeutic Drug Monitoring Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Therapeutic Drug Monitoring Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Therapeutic Drug Monitoring Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Therapeutic Drug Monitoring Revenue Market Share by Type (2021-2026) Table 31. Global Therapeutic Drug Monitoring Revenue Market Share by Type (2027-2032) Table 32. Global Therapeutic Drug Monitoring Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Therapeutic Drug Monitoring Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Therapeutic Drug Monitoring Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Therapeutic Drug Monitoring Revenue Market Share by Application (2021-2026) Table 36. Global Therapeutic Drug Monitoring Revenue Market Share by Application (2027-2032) Table 37. Roche Company Information Table 38. Roche Business Overview Table 39. Roche Therapeutic Drug Monitoring Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Roche Therapeutic Drug Monitoring Product Portfolio Table 41. Roche Recent Development Table 42. Danaher Company Information Table 43. Danaher Business Overview Table 44. Danaher Therapeutic Drug Monitoring Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Danaher Therapeutic Drug Monitoring Product Portfolio Table 46. Danaher Recent Development Table 47. Abbott Company Information Table 48. Abbott Business Overview Table 49. Abbott Therapeutic Drug Monitoring Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Abbott Therapeutic Drug Monitoring Product Portfolio Table 51. Abbott Recent Development Table 52. Thermo Fisher Scientific Company Information Table 53. Thermo Fisher Scientific Business Overview Table 54. Thermo Fisher Scientific Therapeutic Drug Monitoring Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Thermo Fisher Scientific Therapeutic Drug Monitoring Product Portfolio Table 56. Thermo Fisher Scientific Recent Development Table 57. Siemens Healthcare Company Information Table 58. Siemens Healthcare Business Overview Table 59. Siemens Healthcare Therapeutic Drug Monitoring Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Siemens Healthcare Therapeutic Drug Monitoring Product Portfolio Table 61. Siemens Healthcare Recent Development Table 62. Bio-Rad Laboratories Company Information Table 63. Bio-Rad Laboratories Business Overview Table 64. Bio-Rad Laboratories Therapeutic Drug Monitoring Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Bio-Rad Laboratories Therapeutic Drug Monitoring Product Portfolio Table 66. Bio-Rad Laboratories Recent Development Table 67. BioMerieux Company Information Table 68. BioMerieux Business Overview Table 69. BioMerieux Therapeutic Drug Monitoring Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. BioMerieux Therapeutic Drug Monitoring Product Portfolio Table 71. BioMerieux Recent Development Table 72. Sanquin Company Information Table 73. Sanquin Business Overview Table 74. Sanquin Therapeutic Drug Monitoring Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Sanquin Therapeutic Drug Monitoring Product Portfolio Table 76. Sanquin Recent Development Table 77. Becton Dickinson Company Information Table 78. Becton Dickinson Business Overview Table 79. Becton Dickinson Therapeutic Drug Monitoring Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Becton Dickinson Therapeutic Drug Monitoring Product Portfolio Table 81. Becton Dickinson Recent Development Table 82. Quest Diagnostics Company Information Table 83. Quest Diagnostics Business Overview Table 84. Quest Diagnostics Therapeutic Drug Monitoring Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Quest Diagnostics Therapeutic Drug Monitoring Product Portfolio Table 86. Quest Diagnostics Recent Development Table 87. North America Therapeutic Drug Monitoring Revenue by Type (2021-2026) & (US$ Million) Table 88. North America Therapeutic Drug Monitoring Revenue by Type (2027-2032) & (US$ Million) Table 89. North America Therapeutic Drug Monitoring Revenue by Application (2021-2026) & (US$ Million) Table 90. North America Therapeutic Drug Monitoring Revenue by Application (2027-2032) & (US$ Million) Table 91. North America Therapeutic Drug Monitoring Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 92. North America Therapeutic Drug Monitoring Revenue by Country (2021-2026) & (US$ Million) Table 93. North America Therapeutic Drug Monitoring Revenue by Country (US$ Million) & (2027-2032) Table 94. Europe Therapeutic Drug Monitoring Revenue by Type (2021-2026) & (US$ Million) Table 95. Europe Therapeutic Drug Monitoring Revenue by Type (2027-2032) & (US$ Million) Table 96. Europe Therapeutic Drug Monitoring Revenue by Application (2021-2026) & (US$ Million) Table 97. Europe Therapeutic Drug Monitoring Revenue by Application (2027-2032) & (US$ Million) Table 98. Europe Therapeutic Drug Monitoring Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 99. Europe Therapeutic Drug Monitoring Revenue by Country (2021-2026) & (US$ Million) Table 100. Europe Therapeutic Drug Monitoring Revenue by Country (US$ Million) & (2027-2032) Table 101. China Therapeutic Drug Monitoring Revenue by Type (2021-2026) & (US$ Million) Table 102. China Therapeutic Drug Monitoring Revenue by Type (2027-2032) & (US$ Million) Table 103. China Therapeutic Drug Monitoring Revenue by Application (2021-2026) & (US$ Million) Table 104. China Therapeutic Drug Monitoring Revenue by Application (2027-2032) & (US$ Million) Table 105. Asia Therapeutic Drug Monitoring Revenue by Type (2021-2026) & (US$ Million) Table 106. Asia Therapeutic Drug Monitoring Revenue by Type (2027-2032) & (US$ Million) Table 107. Asia Therapeutic Drug Monitoring Revenue by Application (2021-2026) & (US$ Million) Table 108. Asia Therapeutic Drug Monitoring Revenue by Application (2027-2032) & (US$ Million) Table 109. Asia Therapeutic Drug Monitoring Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 110. Asia Therapeutic Drug Monitoring Revenue by Region (US$ Million) & (2021-2026) Table 111. Asia Therapeutic Drug Monitoring Revenue by Region (US$ Million) & (2027-2032) Table 112. SAMEA Therapeutic Drug Monitoring Revenue by Type (2021-2026) & (US$ Million) Table 113. SAMEA Therapeutic Drug Monitoring Revenue by Type (2027-2032) & (US$ Million) Table 114. SAMEA Therapeutic Drug Monitoring Revenue by Application (2021-2026) & (US$ Million) Table 115. SAMEA Therapeutic Drug Monitoring Revenue by Application (2027-2032) & (US$ Million) Table 116. SAMEA Therapeutic Drug Monitoring Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 117. SAMEA Therapeutic Drug Monitoring Revenue by Country (2021-2026) & (US$ Million) Table 118. SAMEA Therapeutic Drug Monitoring Revenue by Country (US$ Million) & (2027-2032) Table 119. Research Programs/Design for This Report Table 120. Authors List of This Report Table 121. Secondary Sources Table 122. Primary Sources List of Figures Figure 1. Therapeutic Drug Monitoring Image Figure 2. Global Therapeutic Drug Monitoring Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Therapeutic Drug Monitoring Market Size Share 2021 VS 2025 VS 2032 Figure 4. Blood Test Image Figure 5. Urine Test Image Figure 6. Saliva Test Image Figure 7. Other Test Image Figure 8. Global Therapeutic Drug Monitoring Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Therapeutic Drug Monitoring Market Size Share 2021 VS 2025 VS 2032 Figure 10. Hospital Labs Image Figure 11. Private Labs Image Figure 12. Others Image Figure 13. Global Therapeutic Drug Monitoring Market Size (US$ Million) & (2021-2032) Figure 14. Global Therapeutic Drug Monitoring Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Therapeutic Drug Monitoring Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Therapeutic Drug Monitoring Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Therapeutic Drug Monitoring Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Therapeutic Drug Monitoring Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Therapeutic Drug Monitoring Revenue Market Share by Type (2021-2032) Figure 21. Global Therapeutic Drug Monitoring Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Therapeutic Drug Monitoring Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Therapeutic Drug Monitoring Revenue Market Share by Application (2021-2032) Figure 24. North America Therapeutic Drug Monitoring Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Therapeutic Drug Monitoring Revenue Share by Type (2021-2032) Figure 26. North America Therapeutic Drug Monitoring Revenue Share by Application (2021-2032) Figure 27. North America Therapeutic Drug Monitoring Revenue Share by Country (2021-2032) Figure 28. United States Therapeutic Drug Monitoring Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Therapeutic Drug Monitoring Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Therapeutic Drug Monitoring Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Therapeutic Drug Monitoring Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Therapeutic Drug Monitoring Revenue Share by Type (2021-2032) Figure 33. Europe Therapeutic Drug Monitoring Revenue Share by Application (2021-2032) Figure 34. Europe Therapeutic Drug Monitoring Revenue Share by Country (2021-2032) Figure 35. Germany Therapeutic Drug Monitoring Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Therapeutic Drug Monitoring Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Therapeutic Drug Monitoring Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Therapeutic Drug Monitoring Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Therapeutic Drug Monitoring Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Therapeutic Drug Monitoring Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Therapeutic Drug Monitoring Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Therapeutic Drug Monitoring Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Therapeutic Drug Monitoring Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Therapeutic Drug Monitoring Revenue Share by Type (2021-2032) Figure 45. China Therapeutic Drug Monitoring Revenue Share by Application (2021-2032) Figure 46. Asia Therapeutic Drug Monitoring Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Therapeutic Drug Monitoring Revenue Share by Type (2021-2032) Figure 48. Asia Therapeutic Drug Monitoring Revenue Share by Application (2021-2032) Figure 49. Asia Therapeutic Drug Monitoring Revenue Share by Region (2021-2032) Figure 50. Japan Therapeutic Drug Monitoring Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Therapeutic Drug Monitoring Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Therapeutic Drug Monitoring Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Therapeutic Drug Monitoring Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Therapeutic Drug Monitoring Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Therapeutic Drug Monitoring Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Therapeutic Drug Monitoring Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Therapeutic Drug Monitoring Revenue Share by Type (2021-2032) Figure 58. SAMEA Therapeutic Drug Monitoring Revenue Share by Application (2021-2032) Figure 59. SAMEA Therapeutic Drug Monitoring Revenue Share by Country (2021-2032) Figure 60. Brazil Therapeutic Drug Monitoring Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Therapeutic Drug Monitoring Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Therapeutic Drug Monitoring Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Therapeutic Drug Monitoring Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Therapeutic Drug Monitoring Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Therapeutic Drug Monitoring Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Therapeutic Drug Monitoring Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Therapeutic Drug Monitoring Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Therapeutic Drug Monitoring Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Therapeutic Drug Monitoring Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Therapeutic Drug Monitoring Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Blood Test
  • Urine Test
  • Saliva Test
  • Other Test
Applications
  • Hospital Labs
  • Private Labs
  • Others
Companies covered
  • Roche
  • Danaher
  • Abbott
  • Thermo Fisher Scientific
  • Siemens Healthcare
  • Bio-Rad Laboratories
  • BioMerieux
  • Sanquin
  • Becton Dickinson
  • Quest Diagnostics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Therapeutic Drug Monitoring Market by Type
  3. 1.2.1 Global Therapeutic Drug Monitoring Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Blood Test
  5. 1.2.3 Urine Test
  6. 1.2.4 Saliva Test
  7. 1.2.5 Other Test
  8. 1.3 Therapeutic Drug Monitoring Market by Application
  9. 1.3.1 Global Therapeutic Drug Monitoring Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Hospital Labs
  11. 1.3.3 Private Labs
  12. 1.3.4 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Therapeutic Drug Monitoring Market Dynamics
  1. 2.1 Therapeutic Drug Monitoring Industry Trends
  2. 2.2 Therapeutic Drug Monitoring Industry Drivers
  3. 2.3 Therapeutic Drug Monitoring Industry Opportunities and Challenges
  4. 2.4 Therapeutic Drug Monitoring Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Therapeutic Drug Monitoring Market Perspective (2021-2032)
  2. 3.2 Global Therapeutic Drug Monitoring Growth Trends by Region
  3. 3.2.1 Global Therapeutic Drug Monitoring Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Therapeutic Drug Monitoring Market Size by Region (2021-2026)
  5. 3.2.3 Global Therapeutic Drug Monitoring Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Therapeutic Drug Monitoring Revenue by Players
  2. 4.1.1 Global Therapeutic Drug Monitoring Revenue by Players (2021-2026)
  3. 4.1.2 Global Therapeutic Drug Monitoring Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Therapeutic Drug Monitoring Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Therapeutic Drug Monitoring Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Therapeutic Drug Monitoring Key Players Headquarters & Area Served
  7. 4.4 Global Therapeutic Drug Monitoring Players, Product Type & Application
  8. 4.5 Global Therapeutic Drug Monitoring Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Therapeutic Drug Monitoring Market CR5 and HHI
  11. 4.6.3 2025 Therapeutic Drug Monitoring Tier 1, Tier 2, and Tier 3
5 Therapeutic Drug Monitoring Market Size by Type
  1. 5.1 Global Therapeutic Drug Monitoring Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Therapeutic Drug Monitoring Revenue by Type (2021-2032)
  3. 5.3 Global Therapeutic Drug Monitoring Revenue Market Share by Type (2021-2032)
6 Therapeutic Drug Monitoring Market Size by Application
  1. 6.1 Global Therapeutic Drug Monitoring Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Therapeutic Drug Monitoring Revenue by Application (2021-2032)
  3. 6.3 Global Therapeutic Drug Monitoring Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Roche
  2. 7.1.1 Roche Company Information
  3. 7.1.2 Roche Business Overview
  4. 7.1.3 Roche Therapeutic Drug Monitoring Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Roche Therapeutic Drug Monitoring Product Portfolio
  6. 7.1.5 Roche Recent Developments
  7. 7.2 Danaher
  8. 7.2.1 Danaher Company Information
  9. 7.2.2 Danaher Business Overview
  10. 7.2.3 Danaher Therapeutic Drug Monitoring Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Danaher Therapeutic Drug Monitoring Product Portfolio
  12. 7.2.5 Danaher Recent Developments
  13. 7.3 Abbott
  14. 7.3.1 Abbott Company Information
  15. 7.3.2 Abbott Business Overview
  16. 7.3.3 Abbott Therapeutic Drug Monitoring Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Abbott Therapeutic Drug Monitoring Product Portfolio
  18. 7.3.5 Abbott Recent Developments
  19. 7.4 Thermo Fisher Scientific
  20. 7.4.1 Thermo Fisher Scientific Company Information
  21. 7.4.2 Thermo Fisher Scientific Business Overview
  22. 7.4.3 Thermo Fisher Scientific Therapeutic Drug Monitoring Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Thermo Fisher Scientific Therapeutic Drug Monitoring Product Portfolio
  24. 7.4.5 Thermo Fisher Scientific Recent Developments
  25. 7.5 Siemens Healthcare
  26. 7.5.1 Siemens Healthcare Company Information
  27. 7.5.2 Siemens Healthcare Business Overview
  28. 7.5.3 Siemens Healthcare Therapeutic Drug Monitoring Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Siemens Healthcare Therapeutic Drug Monitoring Product Portfolio
  30. 7.5.5 Siemens Healthcare Recent Developments
  31. 7.6 Bio-Rad Laboratories
  32. 7.6.1 Bio-Rad Laboratories Company Information
  33. 7.6.2 Bio-Rad Laboratories Business Overview
  34. 7.6.3 Bio-Rad Laboratories Therapeutic Drug Monitoring Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Bio-Rad Laboratories Therapeutic Drug Monitoring Product Portfolio
  36. 7.6.5 Bio-Rad Laboratories Recent Developments
  37. 7.7 BioMerieux
  38. 7.7.1 BioMerieux Company Information
  39. 7.7.2 BioMerieux Business Overview
  40. 7.7.3 BioMerieux Therapeutic Drug Monitoring Revenue and Gross Margin (2021-2026)
  41. 7.7.4 BioMerieux Therapeutic Drug Monitoring Product Portfolio
  42. 7.7.5 BioMerieux Recent Developments
  43. 7.8 Sanquin
  44. 7.8.1 Sanquin Company Information
  45. 7.8.2 Sanquin Business Overview
  46. 7.8.3 Sanquin Therapeutic Drug Monitoring Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Sanquin Therapeutic Drug Monitoring Product Portfolio
  48. 7.8.5 Sanquin Recent Developments
  49. 7.9 Becton Dickinson
  50. 7.9.1 Becton Dickinson Company Information
  51. 7.9.2 Becton Dickinson Business Overview
  52. 7.9.3 Becton Dickinson Therapeutic Drug Monitoring Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Becton Dickinson Therapeutic Drug Monitoring Product Portfolio
  54. 7.9.5 Becton Dickinson Recent Developments
  55. 7.10 Quest Diagnostics
  56. 7.10.1 Quest Diagnostics Company Information
  57. 7.10.2 Quest Diagnostics Business Overview
  58. 7.10.3 Quest Diagnostics Therapeutic Drug Monitoring Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Quest Diagnostics Therapeutic Drug Monitoring Product Portfolio
  60. 7.10.5 Quest Diagnostics Recent Developments
8 North America
  1. 8.1 North America Therapeutic Drug Monitoring Revenue (2021-2032)
  2. 8.2 North America Therapeutic Drug Monitoring Revenue by Type (2021-2032)
  3. 8.2.1 North America Therapeutic Drug Monitoring Revenue by Type (2021-2026)
  4. 8.2.2 North America Therapeutic Drug Monitoring Revenue by Type (2027-2032)
  5. 8.3 North America Therapeutic Drug Monitoring Revenue Share by Type (2021-2032)
  6. 8.4 North America Therapeutic Drug Monitoring Revenue by Application (2021-2032)
  7. 8.4.1 North America Therapeutic Drug Monitoring Revenue by Application (2021-2026)
  8. 8.4.2 North America Therapeutic Drug Monitoring Revenue by Application (2027-2032)
  9. 8.5 North America Therapeutic Drug Monitoring Revenue Share by Application (2021-2032)
  10. 8.6 North America Therapeutic Drug Monitoring Revenue by Country
  11. 8.6.1 North America Therapeutic Drug Monitoring Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Therapeutic Drug Monitoring Revenue by Country (2021-2026)
  13. 8.6.3 North America Therapeutic Drug Monitoring Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Therapeutic Drug Monitoring Revenue (2021-2032)
  2. 9.2 Europe Therapeutic Drug Monitoring Revenue by Type (2021-2032)
  3. 9.2.1 Europe Therapeutic Drug Monitoring Revenue by Type (2021-2026)
  4. 9.2.2 Europe Therapeutic Drug Monitoring Revenue by Type (2027-2032)
  5. 9.3 Europe Therapeutic Drug Monitoring Revenue Share by Type (2021-2032)
  6. 9.4 Europe Therapeutic Drug Monitoring Revenue by Application (2021-2032)
  7. 9.4.1 Europe Therapeutic Drug Monitoring Revenue by Application (2021-2026)
  8. 9.4.2 Europe Therapeutic Drug Monitoring Revenue by Application (2027-2032)
  9. 9.5 Europe Therapeutic Drug Monitoring Revenue Share by Application (2021-2032)
  10. 9.6 Europe Therapeutic Drug Monitoring Revenue by Country
  11. 9.6.1 Europe Therapeutic Drug Monitoring Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Therapeutic Drug Monitoring Revenue by Country (2021-2026)
  13. 9.6.3 Europe Therapeutic Drug Monitoring Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Therapeutic Drug Monitoring Revenue (2021-2032)
  2. 10.2 China Therapeutic Drug Monitoring Revenue by Type (2021-2032)
  3. 10.2.1 China Therapeutic Drug Monitoring Revenue by Type (2021-2026)
  4. 10.2.2 China Therapeutic Drug Monitoring Revenue by Type (2027-2032)
  5. 10.3 China Therapeutic Drug Monitoring Revenue Share by Type (2021-2032)
  6. 10.4 China Therapeutic Drug Monitoring Revenue by Application (2021-2032)
  7. 10.4.1 China Therapeutic Drug Monitoring Revenue by Application (2021-2026)
  8. 10.4.2 China Therapeutic Drug Monitoring Revenue by Application (2027-2032)
  9. 10.5 China Therapeutic Drug Monitoring Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Therapeutic Drug Monitoring Revenue (2021-2032)
  2. 11.2 Asia Therapeutic Drug Monitoring Revenue by Type (2021-2032)
  3. 11.2.1 Asia Therapeutic Drug Monitoring Revenue by Type (2021-2026)
  4. 11.2.2 Asia Therapeutic Drug Monitoring Revenue by Type (2027-2032)
  5. 11.3 Asia Therapeutic Drug Monitoring Revenue Share by Type (2021-2032)
  6. 11.4 Asia Therapeutic Drug Monitoring Revenue by Application (2021-2032)
  7. 11.4.1 Asia Therapeutic Drug Monitoring Revenue by Application (2021-2026)
  8. 11.4.2 Asia Therapeutic Drug Monitoring Revenue by Application (2027-2032)
  9. 11.5 Asia Therapeutic Drug Monitoring Revenue Share by Application (2021-2032)
  10. 11.6 Asia Therapeutic Drug Monitoring Revenue by Country
  11. 11.6.1 Asia Therapeutic Drug Monitoring Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Therapeutic Drug Monitoring Revenue by Country (2021-2026)
  13. 11.6.3 Asia Therapeutic Drug Monitoring Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Therapeutic Drug Monitoring Revenue (2021-2032)
  2. 12.2 SAMEA Therapeutic Drug Monitoring Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Therapeutic Drug Monitoring Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Therapeutic Drug Monitoring Revenue by Type (2027-2032)
  5. 12.3 SAMEA Therapeutic Drug Monitoring Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Therapeutic Drug Monitoring Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Therapeutic Drug Monitoring Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Therapeutic Drug Monitoring Revenue by Application (2027-2032)
  9. 12.5 SAMEA Therapeutic Drug Monitoring Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Therapeutic Drug Monitoring Revenue by Country
  11. 12.6.1 SAMEA Therapeutic Drug Monitoring Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Therapeutic Drug Monitoring Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Therapeutic Drug Monitoring Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst